SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in SELLAS Life Sciences Group, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- 0 vs. Q1 2024
- Shares held
- 4.08M
- −3.67M (−47.3%) vs. Q1 2024
- Total value
- $4.86M
- −$2.97M (−37.9%) vs. Q1 2024
- New holders
- 9
- 12 more added
- Sold out
- 9
- 2 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 193 | $1.08B |
| Q1 2026 | 160 | $228.4M |
| Q4 2025 | 112 | $133.7M |
| Q3 2025 | 94 | $53.1M |
| Q2 2025 | 79 | $58.7M |
| Q1 2025 | 45 | $15.5M |
| Q4 2024 | 31 | $6.47M |
| Q3 2024 | 33 | $6.77M |
| Q2 2024 | 30 | $4.86M |
| Q1 2024 | 30 | $7.82M |
| Q4 2023 | 31 | $3.74M |
| Q3 2023 | 28 | $4.54M |
| Q2 2023 | 25 | $4.91M |
| Q1 2023 | 22 | $4.28M |
| Q4 2022 | 29 | $4.46M |
| Q3 2022 | 28 | $4.42M |
| Q2 2022 | 26 | $6.64M |
| Q1 2022 | 26 | $11.3M |
| Q4 2021 | 27 | $10.1M |
| Q3 2021 | 30 | $17.1M |
| Q2 2021 | 29 | $21.3M |
| Q1 2021 | 31 | $13.3M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding SELLAS Life Sciences Group, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,786,334 | $2.13M | 0.00% | +273,099+18.0% | Added |
| Geode Capital Management, LLC | 517,008 | $615.3K | 0.00% | +243,945+89.3% | Added |
| BlackRock Inc. | 430,368 | $512.1K | 0.00% | +152,150+54.7% | Added |
| Opus Capital Group, LLC | 221,000 | $263.0K | 0.04% | +20,400+10.2% | Added |
| Equitable Holdings, Inc. | 210,000 | $249.9K | 0.00% | +10,000+5.0% | Added |
| Diametric Capital, LP | 153,019 | $182.1K | 0.10% | +153,019 | New |
| Millennium Management LLC | 150,448 | $179.0K | 0.00% | +150,448 | New |
| State Street Corp | 134,029 | $159.5K | 0.00% | +36,900+38.0% | Added |
| Northern Trust Corp | 100,843 | $120.0K | 0.00% | +12,113+13.7% | Added |
| Virtu Financial LLC | 63,843 | $76.0K | 0.01% | +24,414+61.9% | Added |
| Prelude Capital Management, LLC | 55,726 | $66.3K | 0.01% | +55,726 | New |
| LPL Financial LLC | 51,894 | $61.8K | 0.00% | +51,894 | New |
| Mariner, LLC | 44,929 | $53.5K | 0.00% | +19,672+77.9% | Added |
| Renaissance Technologies LLC | 32,446 | $38.6K | 0.00% | +32,446 | New |
| Jane Street Group, LLC | 27,994 | $33.3K | 0.00% | +27,994 | New |
| Independent Financial Group, LLC | 23,250 | $27.7K | 0.00% | +3,000+14.8% | Added |
| Charles Schwab Investment Management Inc | 16,238 | $19.3K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 15,554 | $19.0K | 0.00% | +1,500+10.7% | Added |
| Wedbush Securities Inc | 15,000 | $18.0K | 0.00% | +15,000 | New |
| Tower Research Capital LLC (TRC) | 13,631 | $16.2K | 0.00% | −7,094−34.2% | Reduced |
| Nemes Rush Group LLC | 10,000 | $11.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,297 | $3.92K | 0.00% | −963−22.6% | Reduced |
| Advisor Group Holdings, Inc. | 1,660 | $1.98K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 669 | $1.00K | 0.00% | +446+200.0% | Added |
| Bank of America Corp | 577 | $687 | 0.00% | +577 | New |
| Jones Financial Companies LLLP | 374 | $445 | 0.00% | +374 | New |
| Allworth Financial LP | 150 | $167 | 0.00% | 00.0% | Unchanged |
| JJJ Advisors Inc. | 11 | $14 | 0.00% | 00.0% | Unchanged |
| Parkside Financial Bank & Trust | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 0 | $0 | 0.00% | −4,832,368−100.0% | Sold out |
| Prosperity Financial Group, Inc. | 0 | $0 | 0.00% | −25,385−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −24,750−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,718−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −17,391−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −12,184−100.0% | Sold out |
| Brooklyn FI, LLC | 0 | $0 | 0.00% | −11,178−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −301−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |